Press Releases

BOC Sciences: Peptides Open New Path toward Osteoporosis Treatment

BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is a significant contribution to the therapeutic areas.

BOC Sciences Makes Easy Access to Polymerization Tech

Owing to the continuously upgraded synthesis technologies and analytical abilities, BOC Sciences has performed well in the polymer industry, serving the community with a comprehensive product portfolio and valuable technical support.

BOC Sciences: ADC Analysis and Characterization Support Development, Registration, and Release

BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing comprehensive analysis and characterization technologies.

Metatranscriptome Analysis Service Is Now Available at CD Genomics

Meet CD Genomics at the SITC 37th Annual Meeting

Expanded Offering of Fatty Amines for Diverse Applications

Creative Biogene Develops Custom Lentivirus Services to Support Stable Cell Line Generation

Microbiosci Releases LPS Extraction Service to Support Managing Endotoxins Issues

Creative Biogene Delivers Knockout Mouse Models to Support Gene Editing and Future Studies

Nanoparticle Development Services for Drug Delivery System Research

Acylation Reagents for Gas Chromatography and Other Instrumental Analytical Methods

ExoQuali Products and Protocols Released by Creative Bioarray to Easy Exosome Isolation Process

Histobiolab Provides Over 150 Fish Probes to Satisfy Precise Biological Research Needs

Creative Bioarray Provides 3D Cell Patterning Service Based to Speed up Drug Screening

Press Release: Terumo Pharmaceutical Solutions expands CDMO services outside Japan for global market

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.

Elligo Health Research® Named One of Central Texas’ Fastest-Growing Companies

Alfa Chemistry Announces Offering of Low Molecular Weight Carboxylic Acids

Samsung Biologics Reports Third Quarter 2022 Financial Results

Samsung Biologics a leading contract development and manufacturing organization, released today its fiscal year 2022 third-quarter financial results.

Ardigen supports JUMP-CP Consortium scaling up image-based drug discovery with the world’s largest public Cell Painting dataset

Ardigen has announced that it is supporting the Joint Undertaking in Morphological Profiling-Cell Painting (JUMP-CP) Consortium with its technology and expertise

CD Formulation: One-Stop Pharmaceutical Formulation Solution Makes Drug Development Faster, Easier and More Cost-Effective